Q9BT88
Gene name |
SYT11 |
Protein name |
Synaptotagmin-11 |
Names |
Synaptotagmin XI, SytXI |
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:23208 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q9BT88
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q9BT88-F1 | Predicted | AlphaFoldDB |
280 variants for Q9BT88
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
|
CA342782911 rs1557944467 |
3 | E>A | No |
ClinGen Ensembl |
|
|
CA342782957 rs1393747800 |
6 | N>K | No |
ClinGen TOPMed |
|
|
rs1464573513 CA342782987 |
9 | P>S | No |
ClinGen gnomAD |
|
|
rs776079357 CA1151488 |
10 | S>N | No |
ClinGen ExAC gnomAD |
|
|
rs377646230 CA30959441 |
11 | F>S | No |
ClinGen ESP TOPMed |
|
|
CA1151489 rs779979197 |
12 | D>H | No |
ClinGen ExAC gnomAD |
|
|
CA342787296 rs1220263319 |
13 | V>M | No |
ClinGen TOPMed |
|
|
rs1400731028 CA342787342 |
14 | S>L | No |
ClinGen gnomAD |
|
|
CA342787329 rs1307823220 |
14 | S>P | No |
ClinGen TOPMed |
|
|
CA30962476 rs746738594 |
15 | P>L | No |
ClinGen TOPMed gnomAD |
|
|
rs773398731 CA30962511 |
16 | V>L | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs773398731 CA1151513 |
16 | V>M | No |
ClinGen ExAC TOPMed gnomAD |
|
|
COSM897052 CA342787398 rs1392974436 |
17 | V>M | Variant assessed as Somatic; impact. endometrium [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated NCI-TCGA TOPMed |
|
CA342787433 rs1408308042 |
18 | A>D | No |
ClinGen gnomAD |
|
|
CA1151515 rs544233173 |
19 | G>S | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen 1000Genomes ExAC NCI-TCGA TOPMed gnomAD |
|
rs1372800090 CA342787489 |
20 | L>R | No |
ClinGen TOPMed |
|
|
CA30962551 rs921922610 |
22 | G>E | No |
ClinGen Ensembl |
|
|
CA342787511 rs1232655741 |
22 | G>R | No |
ClinGen gnomAD |
|
|
rs773865820 CA1151516 |
23 | A>T | No |
ClinGen ExAC gnomAD |
|
|
CA30962558 rs899770097 |
25 | V>A | No |
ClinGen TOPMed |
|
|
CA342787582 rs1428063497 |
25 | V>M | No |
ClinGen gnomAD |
|
|
CA1151517 rs145225266 |
28 | V>M | No |
ClinGen ESP ExAC gnomAD |
|
|
rs1571974131 CA342787710 |
29 | C>W | No |
ClinGen Ensembl |
|
|
CA30962577 rs377425025 |
30 | V>A | No |
ClinGen ESP TOPMed |
|
|
CA342787763 rs1481930873 |
31 | S>L | No |
ClinGen gnomAD |
|
|
rs765320971 CA1151524 |
34 | V>A | No |
ClinGen ExAC gnomAD |
|
|
CA1151523 rs201050124 |
34 | V>F | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA1151522 rs201050124 |
34 | V>I | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
|
CA342787885 rs1378804996 |
35 | F>C | No |
ClinGen gnomAD |
|
|
rs1480845804 CA342787924 |
36 | V>A | No |
ClinGen TOPMed |
|
|
CA1151525 rs750379081 |
36 | V>I | No |
ClinGen ExAC gnomAD |
|
|
CA342787977 rs1370377692 |
38 | S>P | No |
ClinGen gnomAD |
|
|
CA342788004 rs1428198671 |
39 | C>Y | No |
ClinGen gnomAD |
|
|
rs748423542 CA1151528 |
41 | H>Q | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA1151527 rs142388437 |
41 | H>R | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs140734493 CA1151529 |
43 | Q>R | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs778204068 CA1151530 |
46 | K>N | No |
ClinGen ExAC gnomAD |
|
|
CA1151531 rs749558009 |
47 | K>T | No |
ClinGen ExAC gnomAD |
|
|
rs371443128 CA30962652 |
48 | Q>* | No |
ClinGen gnomAD |
|
|
rs822522 VAR_047656 CA1151533 |
48 | Q>H | No |
ClinGen UniProt 1000Genomes ESP ExAC TOPMed dbSNP gnomAD |
|
|
rs771315149 CA1151532 |
48 | Q>R | No |
ClinGen ExAC gnomAD |
|
|
CA1151534 rs746345273 |
49 | K>R | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA342788191 rs1487961489 |
51 | P>L | No |
ClinGen gnomAD |
|
| TCGA novel | 55 | F>V | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
| TCGA novel | 57 | H>R | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA1151537 COSM1319905 rs371162872 |
68 | T>N | ovary Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] | No |
ClinGen cosmic curated ESP ExAC NCI-TCGA gnomAD |
|
rs145916199 CA1151541 |
70 | S>C | No |
ClinGen ESP ExAC gnomAD |
|
|
rs145916199 CA1151540 |
70 | S>G | No |
ClinGen ESP ExAC gnomAD |
|
|
CA1151542 rs142925260 |
71 | N>H | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA1151543 rs762934326 |
73 | K>M | No |
ClinGen ExAC gnomAD |
|
|
CA342788347 rs1457648002 |
73 | K>N | No |
ClinGen TOPMed gnomAD |
|
|
rs767736326 CA1151544 |
75 | I>V | No |
ClinGen ExAC |
|
|
CA342788370 rs1393028145 |
77 | K>E | No |
ClinGen gnomAD |
|
|
rs148519088 CA1151547 |
79 | R>Q | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs374184182 CA1151546 |
79 | R>W | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ESP ExAC NCI-TCGA gnomAD |
|
CA30962757 rs866161512 |
81 | D>N | No |
ClinGen Ensembl |
|
|
CA30962763 rs761894157 |
83 | D>N | No |
ClinGen TOPMed |
|
|
rs1298137936 CA342788441 |
88 | E>K | No |
ClinGen gnomAD |
|
|
CA342788446 rs1173205950 |
88 | E>V | No |
ClinGen TOPMed |
|
|
CA342788458 rs1452667689 |
90 | G>E | No |
ClinGen TOPMed |
|
|
rs149832151 CA1151550 |
91 | R>C | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
CA1151551 rs528248189 |
91 | R>H | Variant assessed as Somatic; 4.619e-05 impact. [NCI-TCGA] | No |
ClinGen 1000Genomes ExAC NCI-TCGA TOPMed gnomAD |
|
rs528248189 CA1151552 |
91 | R>L | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
rs1571974300 CA342788474 |
93 | N>T | No |
ClinGen Ensembl |
|
|
CA1151555 rs370384382 |
94 | L>M | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ESP ExAC NCI-TCGA TOPMed gnomAD |
|
rs1247789226 CA342788493 |
96 | V>E | No |
ClinGen gnomAD |
|
|
CA342788490 rs1245597007 |
96 | V>M | No |
ClinGen TOPMed gnomAD |
|
|
rs1447949693 CA342788496 |
97 | D>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
|
rs1414755396 CA342788506 |
98 | A>E | No |
ClinGen TOPMed gnomAD |
|
|
CA1151557 rs761502444 |
98 | A>T | No |
ClinGen ExAC gnomAD |
|
|
CA1151558 rs139689384 |
102 | G>S | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs762988767 CA1151560 |
105 | S>I | No |
ClinGen ExAC gnomAD |
|
|
CA1151561 rs766360750 |
105 | S>R | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA1151563 rs374290876 |
106 | R>* | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ESP ExAC NCI-TCGA TOPMed gnomAD |
|
rs764205420 CA1151564 |
106 | R>Q | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
|
rs1386527357 CA342788554 |
107 | D>Y | No |
ClinGen gnomAD |
|
|
CA1151567 rs757424393 |
109 | D>E | No |
ClinGen ExAC gnomAD |
|
|
rs754058437 CA1151565 |
109 | D>G | No |
ClinGen ExAC gnomAD |
|
|
rs1437274504 CA342788570 |
109 | D>H | No |
ClinGen gnomAD |
|
|
rs1437274504 CA342788569 |
109 | D>N | No |
ClinGen gnomAD |
|
|
CA342788571 rs1437274504 |
109 | D>Y | No |
ClinGen gnomAD |
|
|
CA1151568 rs750724715 |
110 | P>L | No |
ClinGen ExAC gnomAD |
|
|
rs368735654 CA30962822 |
111 | R>T | No |
ClinGen ESP TOPMed |
|
|
rs1557947267 CA342788590 |
112 | G>A | No |
ClinGen Ensembl |
|
|
CA342788586 rs1321955420 |
112 | G>R | No |
ClinGen gnomAD |
|
|
CA1151569 rs758744732 |
115 | S>F | No |
ClinGen ExAC gnomAD |
|
|
CA1151570 rs780488415 |
118 | C>R | No |
ClinGen ExAC gnomAD |
|
|
CA30962834 rs971448004 |
119 | I>V | No |
ClinGen TOPMed gnomAD |
|
|
CA342788636 rs1239129763 |
120 | D>N | No |
ClinGen TOPMed |
|
|
CA342788663 rs1330603125 |
123 | P>H | No |
ClinGen gnomAD |
|
|
rs747516071 CA1151571 |
124 | I>N | No |
ClinGen ExAC gnomAD |
|
|
rs982854274 CA30962839 |
125 | K>T | No |
ClinGen TOPMed |
|
|
CA342788689 rs1243219121 |
127 | D>Y | No |
ClinGen gnomAD |
|
|
CA30962847 rs908640761 |
128 | Y>C | No |
ClinGen TOPMed |
|
| TCGA novel | 130 | E>G | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs768097557 CA1151572 |
131 | E>K | No |
ClinGen ExAC gnomAD |
|
|
CA1151573 rs780703175 |
133 | R>K | No |
ClinGen ExAC gnomAD |
|
|
CA1151574 rs747833603 |
134 | S>N | No |
ClinGen ExAC gnomAD |
|
|
CA342788810 rs1409900875 |
137 | T>I | No |
ClinGen gnomAD |
|
|
CA1151575 rs769504181 |
138 | S>I | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA1151576 rs773154335 |
138 | S>R | No |
ClinGen ExAC gnomAD |
|
|
rs1358537251 CA342788845 |
140 | T>A | No |
ClinGen gnomAD |
|
|
rs144549493 CA1151578 |
141 | P>L | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA1151577 rs749153791 |
141 | P>S | No |
ClinGen ExAC gnomAD |
|
|
CA30962881 rs936000613 |
143 | E>A | No |
ClinGen TOPMed gnomAD |
|
| TCGA novel | 143 | E>D | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs774197657 CA1151579 |
144 | S>R | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs759497839 CA1151580 |
145 | K>E | No |
ClinGen ExAC gnomAD |
|
|
CA30962906 rs932552659 |
146 | T>P | No |
ClinGen TOPMed |
|
|
CA342789014 rs1179516756 |
147 | T>P | No |
ClinGen TOPMed |
|
|
rs764105726 CA1151581 |
147 | T>S | No |
ClinGen ExAC gnomAD |
|
|
rs776735917 CA1151582 |
149 | P>L | No |
ClinGen ExAC gnomAD |
|
|
rs1208619229 CA342789097 |
150 | S>A | No |
ClinGen gnomAD |
|
|
CA342789139 rs1258204968 |
152 | P>S | No |
ClinGen gnomAD |
|
|
CA1151584 rs765496154 |
153 | E>A | No |
ClinGen ExAC gnomAD |
|
|
CA342789277 rs1557947398 |
156 | V>I | No |
ClinGen Ensembl |
|
|
rs532428241 CA1151585 |
158 | L>V | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
CA30962962 rs890768796 |
162 | T>N | No |
ClinGen TOPMed |
|
|
rs755553898 COSM129569 CA1151586 |
164 | S>L | upper_aerodigestive_tract urinary_tract [Cosmic] | No |
ClinGen cosmic curated ExAC TOPMed gnomAD |
|
CA342789633 rs1484523338 |
168 | N>H | No |
ClinGen TOPMed |
|
|
rs550640338 CA1151587 |
170 | P>L | No |
ClinGen 1000Genomes ExAC gnomAD |
|
| TCGA novel | 173 | A>S | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1424477442 CA342789799 |
173 | A>S | No |
ClinGen TOPMed gnomAD |
|
|
CA1151590 rs772498782 |
176 | V>M | No |
ClinGen ExAC gnomAD |
|
|
rs747603431 CA1151591 |
178 | I>V | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA342789904 rs1428846470 |
179 | Q>E | No |
ClinGen gnomAD |
|
|
rs372339571 CA1151592 |
180 | E>K | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA1151594 rs748919583 |
183 | G>R | No |
ClinGen ExAC TOPMed gnomAD |
|
| TCGA novel | 187 | M>V | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs145851767 CA1151596 |
188 | D>G | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs1306241722 CA342790109 |
188 | D>N | No |
ClinGen gnomAD |
|
|
rs761301950 CA1151597 |
192 | Q>H | No |
ClinGen ExAC gnomAD |
|
| TCGA novel | 201 | T>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA1151600 rs761943579 |
203 | L>R | No |
ClinGen ExAC gnomAD |
|
|
rs865986360 CA30963027 |
205 | D>E | No |
ClinGen TOPMed gnomAD |
|
|
rs1410247008 CA342790418 |
206 | K>R | No |
ClinGen gnomAD |
|
|
rs773469168 CA1151602 |
207 | R>Q | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA342790423 rs1322433084 |
207 | R>W | No |
ClinGen gnomAD |
|
|
rs763110988 CA1151603 |
208 | H>L | No |
ClinGen ExAC gnomAD |
|
|
rs1418478405 CA342790445 |
209 | R>Q | No |
ClinGen TOPMed |
|
|
CA342790458 rs1325947548 |
210 | V>A | No |
ClinGen gnomAD |
|
|
CA30963030 rs112686501 |
215 | L>P | No |
ClinGen Ensembl |
|
|
CA30963035 rs556015196 |
216 | R>Q | No |
ClinGen gnomAD |
|
|
rs1557947475 CA342790527 |
216 | R>W | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen Ensembl NCI-TCGA |
|
rs766683490 CA1151604 |
217 | K>N | No |
ClinGen ExAC gnomAD |
|
|
CA342790546 rs1228239731 |
217 | K>R | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
|
rs1341909604 CA342790566 |
219 | L>V | No |
ClinGen gnomAD |
|
|
CA342790641 rs751883423 |
224 | D>E | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1463849694 CA342790646 |
225 | E>K | No |
ClinGen gnomAD |
|
|
VAR_047657 CA30963046 rs17853892 |
231 | G>V | No |
ClinGen UniProt Ensembl dbSNP |
|
|
CA342790743 rs1320095901 |
232 | I>V | No |
ClinGen TOPMed gnomAD |
|
|
CA1151606 rs755453226 |
234 | Y>C | No |
ClinGen ExAC gnomAD |
|
|
rs1186588507 CA342790812 |
237 | L>V | No |
ClinGen gnomAD |
|
|
CA30963066 rs1005541281 |
238 | Q>H | No |
ClinGen Ensembl |
|
|
rs753253141 CA1151608 |
239 | D>E | No |
ClinGen ExAC gnomAD |
|
|
CA1151610 rs777400944 |
243 | H>L | No |
ClinGen ExAC TOPMed gnomAD |
|
| TCGA novel | 246 | V>S | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA342790939 rs1557947518 |
247 | L>V | No |
ClinGen Ensembl |
|
|
rs1165028817 CA342790961 |
248 | S>R | No |
ClinGen gnomAD |
|
|
CA342790979 rs1387261737 |
250 | D>N | No |
ClinGen gnomAD |
|
|
CA342790989 rs1435097534 |
251 | R>C | No |
ClinGen gnomAD |
|
|
CA30963077 rs982800293 COSM424092 |
251 | R>H | breast [Cosmic] | No |
ClinGen cosmic curated TOPMed gnomAD |
|
CA1151611 rs748972934 |
254 | R>P | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA1151612 rs748972934 |
254 | R>Q | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1328613589 CA342791007 COSM897055 |
254 | R>W | Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated NCI-TCGA gnomAD |
|
CA1151614 rs745623175 |
258 | I>T | No |
ClinGen ExAC gnomAD |
|
|
rs1557947543 CA342791046 |
260 | E>G | No |
ClinGen Ensembl |
|
|
CA1151617 rs746939757 |
260 | E>K | No |
ClinGen ExAC gnomAD |
|
|
rs1206795833 CA342791076 |
262 | M>I | No |
ClinGen gnomAD |
|
|
rs1328535349 CA342791064 |
262 | M>L | No |
ClinGen TOPMed gnomAD |
|
|
rs1328535349 CA342791066 |
262 | M>V | No |
ClinGen TOPMed gnomAD |
|
|
rs1325689135 CA342791085 |
263 | V>E | No |
ClinGen TOPMed |
|
|
CA1151618 rs769879129 |
263 | V>M | No |
ClinGen ExAC gnomAD |
|
|
CA1151622 rs774414460 |
266 | A>V | No |
ClinGen ExAC gnomAD |
|
|
CA342791135 rs1395155064 |
267 | G>A | No |
ClinGen TOPMed |
|
|
rs200496974 CA1151625 |
268 | V>A | No |
ClinGen ExAC gnomAD |
|
|
rs200496974 CA1151624 |
268 | V>G | No |
ClinGen ExAC gnomAD |
|
|
CA30963151 rs932524497 |
268 | V>L | No |
ClinGen TOPMed gnomAD |
|
|
CA342791160 rs763699683 CA1151627 |
269 | D>E | No |
ClinGen ExAC gnomAD |
|
|
CA1151626 rs761204826 |
269 | D>G | No |
ClinGen ExAC gnomAD |
|
|
rs756878441 CA1151630 |
271 | S>G | No |
ClinGen ExAC |
|
|
rs996287931 CA30963165 |
271 | S>I | No |
ClinGen Ensembl |
|
|
rs756878441 CA1151629 |
271 | S>R | No |
ClinGen ExAC |
|
|
rs750043360 CA1151631 |
273 | G>D | No |
ClinGen ExAC gnomAD |
|
|
rs912492040 CA30963170 |
274 | K>T | No |
ClinGen TOPMed |
|
|
CA342791232 rs1571974788 |
275 | V>G | No |
ClinGen Ensembl |
|
|
rs1474918144 CA342791237 |
276 | Q>K | No |
ClinGen TOPMed |
|
|
rs1370958451 CA342791255 |
277 | L>V | No |
ClinGen TOPMed |
|
|
CA342791313 rs1455461887 |
281 | I>T | No |
ClinGen TOPMed gnomAD |
|
|
rs779769270 CA1151633 |
283 | K>Q | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs746955768 CA1151634 |
283 | K>R | No |
ClinGen ExAC gnomAD |
|
|
CA1151635 rs768542179 |
287 | Q>H | No |
ClinGen ExAC gnomAD |
|
|
CA30969720 rs955980732 |
290 | I>F | No |
ClinGen TOPMed gnomAD |
|
|
rs951692048 CA30969721 |
292 | R>T | No |
ClinGen Ensembl |
|
| TCGA novel | 293 | G>R | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA30969744 rs1008879112 |
294 | E>A | No |
ClinGen Ensembl |
|
|
CA342795545 rs781147465 |
295 | L>F | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA1151653 rs781147465 |
295 | L>V | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1197174378 CA342795556 |
296 | Q>H | No |
ClinGen gnomAD |
|
|
CA30969763 rs770179565 |
300 | S>T | No |
ClinGen Ensembl |
|
|
CA342795598 rs1450512882 |
302 | Q>* | No |
ClinGen gnomAD |
|
|
rs1196068668 CA342795616 |
303 | P>A | No |
ClinGen gnomAD |
|
|
rs1196068668 CA342795618 |
303 | P>S | No |
ClinGen gnomAD |
|
| TCGA novel | 307 | R>I | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA342795694 rs1571981291 |
308 | M>T | No |
ClinGen Ensembl |
|
|
CA1151656 rs778798535 |
310 | V>L | No |
ClinGen ExAC gnomAD |
|
|
CA1151657 rs746104700 |
311 | V>L | No |
ClinGen ExAC gnomAD |
|
|
rs746104700 CA1151658 |
311 | V>M | No |
ClinGen ExAC gnomAD |
|
|
CA342795761 rs1389930101 |
312 | V>I | No |
ClinGen gnomAD |
|
|
rs925408078 CA30969784 |
315 | A>S | No |
ClinGen gnomAD |
|
|
CA342795827 rs925408078 |
315 | A>T | No |
ClinGen gnomAD |
|
|
CA1151659 rs776016732 |
317 | H>Y | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA1151660 rs747423514 |
319 | P>L | No |
ClinGen ExAC gnomAD |
|
|
rs762173276 CA1151663 |
320 | K>N | No |
ClinGen ExAC gnomAD |
|
|
CA1151664 rs764811206 |
323 | I>V | No |
ClinGen ExAC gnomAD |
|
|
rs1489688520 CA342796032 |
324 | T>I | No |
ClinGen TOPMed |
|
|
rs762617645 CA1151666 |
325 | G>S | No |
ClinGen ExAC TOPMed |
|
|
CA342796243 rs770153506 |
331 | Y>D | No |
ClinGen ExAC gnomAD |
|
|
rs770153506 CA1151681 |
331 | Y>H | No |
ClinGen ExAC gnomAD |
|
|
CA342796344 rs1224414336 |
335 | N>S | No |
ClinGen TOPMed |
|
|
CA1151683 rs369297239 |
336 | V>I | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs774048862 CA1151685 |
339 | G>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA342796443 rs1423506494 |
340 | R>G | No |
ClinGen gnomAD |
|
|
COSM897058 rs759130814 CA1151686 |
342 | R>C | Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated ExAC NCI-TCGA gnomAD |
|
CA30970210 rs929343111 |
342 | R>H | No |
ClinGen TOPMed gnomAD |
|
|
CA342796489 rs929343111 |
342 | R>L | No |
ClinGen TOPMed gnomAD |
|
|
CA30970215 COSM108234 rs138327201 |
343 | I>V | skin [Cosmic] | No |
ClinGen cosmic curated Ensembl |
|
CA342796627 rs1158437866 |
349 | H>Q | No |
ClinGen TOPMed gnomAD |
|
|
rs1305379040 CA342796664 |
351 | K>R | No |
ClinGen TOPMed |
|
|
CA342796700 rs1557951348 |
353 | C>R | No |
ClinGen Ensembl |
|
|
CA342796702 rs1455240003 |
353 | C>Y | No |
ClinGen gnomAD |
|
|
rs1405926654 CA342796765 |
357 | P>H | No |
ClinGen TOPMed |
|
|
CA1151690 rs756097475 |
358 | I>T | No |
ClinGen ExAC gnomAD |
|
|
CA1151689 rs151122665 |
358 | I>V | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs1294729485 CA342796793 |
359 | F>V | No |
ClinGen gnomAD |
|
|
CA342796824 rs1355633081 |
360 | N>S | No |
ClinGen gnomAD |
|
|
CA30970246 rs900119413 |
361 | E>V | No |
ClinGen Ensembl |
|
|
CA1151692 rs768745300 |
366 | D>N | No |
ClinGen ExAC gnomAD |
|
|
CA1151694 rs780229063 |
368 | P>S | No |
ClinGen ExAC gnomAD |
|
|
rs1483123483 CA342796954 |
369 | T>A | No |
ClinGen gnomAD |
|
|
rs538608004 CA1151696 |
370 | D>E | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA342796968 rs1209106970 |
370 | D>H | No |
ClinGen gnomAD |
|
|
CA342796976 rs1557951398 |
371 | L>R | No |
ClinGen Ensembl |
|
|
CA1151697 rs141959462 |
373 | P>L | No |
ClinGen ESP ExAC TOPMed |
|
|
rs1181581688 CA342796998 |
375 | I>V | No |
ClinGen gnomAD |
|
|
rs748512443 CA1151698 |
376 | S>G | No |
ClinGen ExAC gnomAD |
|
|
CA30970332 rs764611434 |
377 | I>V | No |
ClinGen Ensembl |
|
|
COSM1228309 CA1151701 rs749783469 |
381 | V>I | large_intestine [Cosmic] | No |
ClinGen cosmic curated ExAC TOPMed gnomAD |
|
rs749783469 CA1151702 |
381 | V>L | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA1151703 rs560124002 |
382 | I>T | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
rs751864401 CA1151704 |
383 | D>N | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA1151707 rs540504685 COSM529240 |
385 | D>N | lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] | No |
ClinGen cosmic curated ExAC NCI-TCGA TOPMed gnomAD |
|
rs1226039485 CA342797073 |
386 | R>C | No |
ClinGen TOPMed gnomAD |
|
|
CA30970378 rs893985979 |
386 | R>H | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed gnomAD |
|
rs753844895 CA1151709 |
390 | N>D | No |
ClinGen ExAC TOPMed gnomAD |
|
| TCGA novel | 395 | R>M | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA1151713 rs755065675 |
400 | A>V | No |
ClinGen ExAC gnomAD |
|
|
CA342797202 rs1481651013 |
402 | S>N | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
|
rs147787530 CA30970399 |
403 | V>F | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs147787530 CA1151714 |
403 | V>I | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
CA342797231 rs1424377881 |
404 | T>P | No |
ClinGen gnomAD |
|
|
CA342797269 rs1452453248 |
406 | S>T | No |
ClinGen gnomAD |
|
|
CA342797297 rs1328322671 |
408 | A>T | No |
ClinGen TOPMed |
|
|
rs1571981842 CA342797362 |
411 | W>G | No |
ClinGen Ensembl |
|
| TCGA novel | 412 | R>I | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1571981854 CA342797438 |
415 | C>G | No |
ClinGen Ensembl |
|
| TCGA novel | 415 | C>Y | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA1151716 rs756494595 |
416 | E>K | No |
ClinGen ExAC gnomAD |
|
|
CA342797457 rs1571981890 |
417 | S>T | No |
ClinGen Ensembl |
|
|
CA1151717 rs140896977 |
419 | R>C | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs140896977 CA342797468 |
419 | R>G | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
CA1151718 rs749800041 |
419 | R>H | Variant assessed as Somatic; 4.64e-05 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
|
rs749800041 CA30970446 |
419 | R>L | No |
ClinGen ExAC gnomAD |
|
|
rs1292399238 CA342797471 |
420 | K>E | No |
ClinGen gnomAD |
|
|
CA342797476 rs1178431127 |
420 | K>N | No |
ClinGen TOPMed |
|
|
CA1151720 rs778415556 |
421 | P>R | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA342797818 rs1428296536 |
422 | V>M | No |
ClinGen TOPMed |
|
|
rs1306138232 CA342797859 |
424 | K>R | No |
ClinGen gnomAD |
|
|
CA1151723 rs141914865 |
429 | S>N | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA1151722 rs141914865 |
429 | S>T | No |
ClinGen ESP ExAC TOPMed gnomAD |
No associated diseases with Q9BT88
6 regional properties for Q9BT88
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | C2 domain | 157 - 279 | IPR000008-1 |
| domain | C2 domain | 291 - 426 | IPR000008-2 |
| domain | Synaptotagmin | 161 - 176 | IPR001565-1 |
| domain | Synaptotagmin | 176 - 189 | IPR001565-2 |
| domain | Synaptotagmin | 233 - 248 | IPR001565-3 |
| domain | Synaptotagmin | 253 - 263 | IPR001565-4 |
Functions
26 GO annotations of cellular component
| Name | Definition |
|---|---|
| anchoring junction | A cell junction that mechanically attaches a cell (and its cytoskeleton) to neighboring cells or to the extracellular matrix. |
| axon | The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter. |
| clathrin-coated vesicle membrane | The lipid bilayer surrounding a clathrin-coated vesicle. |
| dendrite | A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body. |
| dendritic spine | A small, membranous protrusion from a dendrite that forms a postsynaptic compartment, typically receiving input from a single presynapse. They function as partially isolated biochemical and an electrical compartments. Spine morphology is variable:they can be thin, stubby, mushroom, or branched, with a continuum of intermediate morphologies. They typically terminate in a bulb shape, linked to the dendritic shaft by a restriction. Spine remodeling is though to be involved in synaptic plasticity. |
| early phagosome | A membrane-bounded intracellular vesicle as initially formed upon the ingestion of particulate material by phagocytosis. |
| excitatory synapse | A synapse in which an action potential in the presynaptic cell increases the probability of an action potential occurring in the postsynaptic cell. |
| exocytic vesicle | A transport vesicle that mediates transport from an intracellular compartment to the plasma membrane, and fuses with the plasma membrane to release various cargo molecules, such as proteins or hormones, by exocytosis. |
| inhibitory synapse | A synapse in which an action potential in the presynaptic cell reduces the probability of an action potential occurring in the postsynaptic cell. |
| integral component of plasma membrane | The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| lysosomal membrane | The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm. |
| lysosome | A small lytic vacuole that has cell cycle-independent morphology found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions. |
| neuron projection | A prolongation or process extending from a nerve cell, e.g. an axon or dendrite. |
| perikaryon | The portion of the cell soma (neuronal cell body) that excludes the nucleus. |
| phagocytic cup | An invagination of the cell membrane formed by an actin dependent process during phagocytosis. Following internalization it is converted into a phagosome. |
| phagocytic vesicle | A membrane-bounded intracellular vesicle that arises from the ingestion of particulate material by phagocytosis. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| postsynaptic density | An electron dense network of proteins within and adjacent to the postsynaptic membrane of an asymmetric, neuron-neuron synapse. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components. |
| presynapse | The part of a synapse that is part of the presynaptic cell. |
| presynaptic active zone membrane | The membrane portion of the presynaptic active zone; it is the site where docking and fusion of synaptic vesicles occurs for the release of neurotransmitters. |
| recycling endosome | An organelle consisting of a network of tubules that functions in targeting molecules, such as receptors transporters and lipids, to the plasma membrane. |
| recycling endosome membrane | The lipid bilayer surrounding a recycling endosome. |
| synapse | The junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber or a glial cell. As the axon approaches the synapse it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane. |
| synaptic vesicle | A secretory organelle, typically 50 nm in diameter, of presynaptic nerve terminals; accumulates in high concentrations of neurotransmitters and secretes these into the synaptic cleft by fusion with the 'active zone' of the presynaptic plasma membrane. |
| trans-Golgi network | The network of interconnected tubular and cisternal structures located within the Golgi apparatus on the side distal to the endoplasmic reticulum, from which secretory vesicles emerge. The trans-Golgi network is important in the later stages of protein secretion where it is thought to play a key role in the sorting and targeting of secreted proteins to the correct destination. |
| vesicle | Any small, fluid-filled, spherical organelle enclosed by membrane. |
9 GO annotations of molecular function
| Name | Definition |
|---|---|
| beta-tubulin binding | Binding to the microtubule constituent protein beta-tubulin. |
| calcium ion binding | Binding to a calcium ion (Ca2+). |
| calcium-dependent phospholipid binding | Binding to a phospholipid, a class of lipids containing phosphoric acid as a mono- or diester, in the presence of calcium. |
| clathrin binding | Binding to a clathrin heavy or light chain, the main components of the coat of coated vesicles and coated pits, and which also occurs in synaptic vesicles. |
| identical protein binding | Binding to an identical protein or proteins. |
| phosphatidylserine binding | Binding to phosphatidylserine, a class of glycophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of L-serine. |
| SNARE binding | Binding to a SNARE (soluble N-ethylmaleimide-sensitive factor attached protein receptor) protein. |
| translation initiation factor binding | Binding to a translation initiation factor, any polypeptide factor involved in the initiation of ribosome-mediated translation. |
| ubiquitin protein ligase binding | Binding to a ubiquitin protein ligase enzyme, any of the E3 proteins. |
23 GO annotations of biological process
| Name | Definition |
|---|---|
| autophagy | The cellular catabolic process in which cells digest parts of their own cytoplasm; allows for both recycling of macromolecular constituents under conditions of cellular stress and remodeling the intracellular structure for cell differentiation. |
| calcium ion regulated lysosome exocytosis | The process of secretion by a cell that results in the release of intracellular molecules contained within a lysosome by fusion of the vesicle with the plasma membrane of a cell, induced by a rise in cytosolic calcium-ion levels. |
| calcium-ion regulated exocytosis | The release of intracellular molecules (e.g. hormones, matrix proteins) contained within a membrane-bounded vesicle by fusion of the vesicle with the plasma membrane of a cell, induced by a rise in cytosolic calcium-ion levels. |
| cellular response to calcium ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus. |
| establishment of vesicle localization | The directed movement of a vesicle to a specific location. |
| learning | Any process in an organism in which a relatively long-lasting adaptive behavioral change occurs as the result of experience. |
| memory | The activities involved in the mental information processing system that receives (registers), modifies, stores, and retrieves informational stimuli. The main stages involved in the formation and retrieval of memory are encoding (processing of received information by acquisition), storage (building a permanent record of received information as a result of consolidation) and retrieval (calling back the stored information and use it in a suitable way to execute a given task). |
| negative regulation of cytokine production | Any process that stops, prevents, or reduces the rate of production of a cytokine. |
| negative regulation of dopamine secretion | Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of dopamine. |
| negative regulation of endocytosis | Any process that stops, prevents, or reduces the frequency, rate or extent of endocytosis. |
| negative regulation of interleukin-6 production | Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-6 production. |
| negative regulation of microglial cell activation | Any process that stops, prevents or reduces the frequency, rate or extent of microglial cell activation. |
| negative regulation of neurotransmitter secretion | Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of a neurotransmitter. |
| negative regulation of phagocytosis | Any process that stops, prevents, or reduces the frequency, rate or extent of phagocytosis. |
| negative regulation of tumor necrosis factor production | Any process that stops, prevents, or reduces the frequency, rate, or extent of tumor necrosis factor production. |
| plasma membrane repair | The resealing of a cell plasma membrane after cellular wounding due to, for instance, mechanical stress. |
| positive regulation of protein localization to phagocytic vesicle | Any process that activates or increases the frequency, rate or extent of protein localization to phagocytic vesicle. |
| regulation of calcium ion-dependent exocytosis | Any process that modulates the frequency, rate or extent of calcium ion-dependent exocytosis. |
| regulation of defense response to bacterium | Any process that modulates the frequency, rate or extent of defense response to bacterium. |
| regulation of dopamine secretion | Any process that modulates the frequency, rate or extent of the regulated release of dopamine. |
| regulation of phagosome maturation | Any process that modulates the frequency, rate or extent of phagosome maturation. |
| vesicle fusion | Fusion of the membrane of a transport vesicle with its target membrane. |
| vesicle-mediated transport | A cellular transport process in which transported substances are moved in membrane-bounded vesicles; transported substances are enclosed in the vesicle lumen or located in the vesicle membrane. The process begins with a step that directs a substance to the forming vesicle, and includes vesicle budding and coating. Vesicles are then targeted to, and fuse with, an acceptor membrane. |
45 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| P48018 | SYT1 | Synaptotagmin-1 | Bos taurus (Bovine) | PR |
| P21521 | Syt1 | Synaptotagmin 1 | Drosophila melanogaster (Fruit fly) | PR |
| Q86XP0 | PLA2G4D | Cytosolic phospholipase A2 delta | Homo sapiens (Human) | PR |
| Q9HCH5 | SYTL2 | Synaptotagmin-like protein 2 | Homo sapiens (Human) | PR |
| Q96C24 | SYTL4 | Synaptotagmin-like protein 4 | Homo sapiens (Human) | PR |
| Q8N9U0 | TC2N | Tandem C2 domains nuclear protein | Homo sapiens (Human) | PR |
| Q8TDW5 | SYTL5 | Synaptotagmin-like protein 5 | Homo sapiens (Human) | PR |
| Q8IYJ3 | SYTL1 | Synaptotagmin-like protein 1 | Homo sapiens (Human) | PR |
| P21579 | SYT1 | Synaptotagmin-1 | Homo sapiens (Human) | PR |
| Q6XYQ8 | SYT10 | Synaptotagmin-10 | Homo sapiens (Human) | PR |
| Q7L8C5 | SYT13 | Synaptotagmin-13 | Homo sapiens (Human) | PR |
| Q86SS6 | SYT9 | Synaptotagmin-9 | Homo sapiens (Human) | PR |
| Q9BQG1 | SYT3 | Synaptotagmin-3 | Homo sapiens (Human) | PR |
| O00445 | SYT5 | Synaptotagmin-5 | Homo sapiens (Human) | PR |
| Q9H2B2 | SYT4 | Synaptotagmin-4 | Homo sapiens (Human) | PR |
| O43581 | SYT7 | Synaptotagmin-7 | Homo sapiens (Human) | PR |
| Q9BQS2 | SYT15 | Synaptotagmin-15 | Homo sapiens (Human) | PR |
| Q5T7P8 | SYT6 | Synaptotagmin-6 | Homo sapiens (Human) | PR |
| P40749 | Syt4 | Synaptotagmin-4 | Mus musculus (Mouse) | PR |
| Q9EQT6 | Syt13 | Synaptotagmin-13 | Mus musculus (Mouse) | PR |
| Q9R0N4 | Syt10 | Synaptotagmin-10 | Mus musculus (Mouse) | PR |
| Q99N80 | Sytl1 | Synaptotagmin-like protein 1 | Mus musculus (Mouse) | PR |
| Q9R0Q1 | Sytl4 | Synaptotagmin-like protein 4 | Mus musculus (Mouse) | PR |
| Q8C6N3 | Syt15 | Synaptotagmin-15 | Mus musculus (Mouse) | PR |
| Q920N7 | Syt12 | Synaptotagmin-12 | Mus musculus (Mouse) | PR |
| Q80T23 | Sytl5 | Synaptotagmin-like protein 5 | Mus musculus (Mouse) | PR |
| Q9R0N5 | Syt5 | Synaptotagmin-5 | Mus musculus (Mouse) | PR |
| Q9R0N9 | Syt9 | Synaptotagmin-9 | Mus musculus (Mouse) | PR |
| Q9R0N8 | Syt6 | Synaptotagmin-6 | Mus musculus (Mouse) | PR |
| Q50L43 | Pla2g4d | Cytosolic phospholipase A2 delta | Mus musculus (Mouse) | PR |
| P46096 | Syt1 | Synaptotagmin-1 | Mus musculus (Mouse) | PR |
| O35681 | Syt3 | Synaptotagmin-3 | Mus musculus (Mouse) | PR |
| P46097 | Syt2 | Synaptotagmin-2 | Mus musculus (Mouse) | PR |
| Q91XT6 | Tc2n | Tandem C2 domains nuclear protein | Mus musculus (Mouse) | PR |
| Q9R0N3 | Syt11 | Synaptotagmin-11 | Mus musculus (Mouse) | PR |
| Q812E4 | Sytl5 | Synaptotagmin-like protein 5 | Rattus norvegicus (Rat) | PR |
| Q925B5 | Syt13 | Synaptotagmin-13 | Rattus norvegicus (Rat) | PR |
| O08625 | Syt10 | Synaptotagmin-10 | Rattus norvegicus (Rat) | PR |
| P47861 | Syt5 | Synaptotagmin-5 | Rattus norvegicus (Rat) | PR |
| Q62746 | Syt6 | Synaptotagmin-6 | Rattus norvegicus (Rat) | PR |
| P97610 | Syt12 | Synaptotagmin-12 | Rattus norvegicus (Rat) | PR |
| P40748 | Syt3 | Synaptotagmin-3 | Rattus norvegicus (Rat) | PR |
| Q925C0 | Syt9 | Synaptotagmin-9 | Rattus norvegicus (Rat) | PR |
| P59926 | Syt15 | Synaptotagmin-15 | Rattus norvegicus (Rat) | PR |
| P21707 | Syt1 | Synaptotagmin-1 | Rattus norvegicus (Rat) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MAEITNIRPS | FDVSPVVAGL | IGASVLVVCV | SVTVFVWSCC | HQQAEKKQKN | PPYKFIHMLK |
| 70 | 80 | 90 | 100 | 110 | 120 |
| GISIYPETLS | NKKKIIKVRR | DKDGPGREGG | RRNLLVDAAE | AGLLSRDKDP | RGPSSGSCID |
| 130 | 140 | 150 | 160 | 170 | 180 |
| QLPIKMDYGE | ELRSPITSLT | PGESKTTSPS | SPEEDVMLGS | LTFSVDYNFP | KKALVVTIQE |
| 190 | 200 | 210 | 220 | 230 | 240 |
| AHGLPVMDDQ | TQGSDPYIKM | TILPDKRHRV | KTRVLRKTLD | PVFDETFTFY | GIPYSQLQDL |
| 250 | 260 | 270 | 280 | 290 | 300 |
| VLHFLVLSFD | RFSRDDVIGE | VMVPLAGVDP | STGKVQLTRD | IIKRNIQKCI | SRGELQVSLS |
| 310 | 320 | 330 | 340 | 350 | 360 |
| YQPVAQRMTV | VVLKARHLPK | MDITGLSGNP | YVKVNVYYGR | KRIAKKKTHV | KKCTLNPIFN |
| 370 | 380 | 390 | 400 | 410 | 420 |
| ESFIYDIPTD | LLPDISIEFL | VIDFDRTTKN | EVVGRLILGA | HSVTASGAEH | WREVCESPRK |
| 430 | |||||
| PVAKWHSLSE | Y |